Oversubscribed Shortfall Offer & Placement raise 1.75m
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Curvebeam AI Ltd. has announced the results of its oversubscribed Shortfall Offer and Placement, raising funds to support its expansion in China. CEO Greg Brown highlighted the recent FDA clearance of their CT-based Bone Mineral Density technology as a key milestone for future growth. The funds will be allocated towards sales, marketing, research and development, and supply chain costs related to the China market launch.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Curvebeam AI
- FDA 510(k) Clearance CT-based BMD Technology
- SPP Offer Results
- Annual Report to shareholders - FY2026
- CVB Secures 5M Placement & Announces SPP
- Q3 FY26 Quarterly Results Investor Webinar
Later from Curvebeam AI
- Trading Halt
- CVB Achieves NMPA Approval for HiRise in China
- Quarterly Activities/Appendix 4C Cash Flow Report
- CVB Quarterly Investor Presentation - Q1 FY27
Follow Curvebeam AI into a list and get an email when it puts out news.
Follow Curvebeam AI